SK Inc旗下子公司SK Pharmteco宣布与孤儿药治疗加速器(Orphan Therapeutics Accelerator)建立战略合作关系,双方将共同致力于罕见病疗法的开发与生产。此次合作旨在整合双方在各自领域的专长,加速创新疗法的研发进程,以满足全球罕见病患者的医疗需求。
SK Inc旗下子公司SK Pharmteco宣布与孤儿药治疗加速器(Orphan Therapeutics Accelerator)建立战略合作关系,双方将共同致力于罕见病疗法的开发与生产。此次合作旨在整合双方在各自领域的专长,加速创新疗法的研发进程,以满足全球罕见病患者的医疗需求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.